CASP3 and neuroblastoma: In terms of its molecular mechanism of action against neuroblastoma tumors, DpC significantly increased levels of phosphorylated JNK, neuroglobin, cytoglobin, and cleaved caspase 3 and 9, while simultaneously decreasing inhibitory IĸBα levels in vitro (Fig. 8).